Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by wildbird1on Aug 28, 2023 11:28am
237 Views
Post# 35608128

RE:RE:Interim Data...

RE:RE:Interim Data...
DJDawg wrote:
Based on what is pending and how hard it can be to move the % when you have a certain number already counted, my prediction is that 90,180, 360, 450 pretty much stay the same. 270 should get a bump up based on the big wave of CR at 180 from last time.

Regardless, evein if the CR doesn't change too much, you get higher statistical strength based on the enlargening sample size. e.g. 60% of 20 sounds promising, but 60% of 60 is more confidence inspiring that the first 20 were not just a bit lucky.




If you look at the last swimmer plot(May 31,2023), you will notice that, of the last 14 patients treated(90Day+), 11/14 are CR(complete Response).
That is a very big 80%CR "at any point in time" for these 14 patients.

For now the 450 Day CR% will not change(or very little change), but in due time some of these 11 green dots patients will eventually reflect on the 450 day CR% that will increase accordingly.

This 80%CR "at any point in time" indicate that TLT is getting better and better at fine tuning it Ruvidar(TLD-1433) treatment, as this fine tuning progress we could be pleasantly surprise by future CR% at 450 day.

The future look's great.




<< Previous
Bullboard Posts
Next >>